Paper35228751
Cross-cohort gut microbiome associations with immune checkpoint inhibitor response in advanced melanoma.
Lee KA and 39 others. Nat Med, 2022. Cited by 392 papers, by iCite.
Cite this record
ConductScience Library. Cross-cohort gut microbiome associations with immune checkpoint inhibitor response in advanced melanoma. Papers, record 35228751. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35228751
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Gastrointestinal Microbiome | Major topic |
| Melanoma | Major topic |
| Skin Neoplasms | Major topic |
| Humans | |
| Immune Checkpoint Inhibitors | |
| Reproducibility of Results |
Source PubMed
Grants10
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| A22902 | Cancer Research UK | United Kingdom | PubMed | PubMed | |
| A27412 | Cancer Research UK | United Kingdom | PubMed | PubMed | |
| MR/M019012/1 | Medical Research Council | United Kingdom | PubMed | PubMed | |
| 19167 | Cancer Research UK | United Kingdom | PubMed | PubMed | |
| 11963 | Cancer Research UK | United Kingdom | PubMed | PubMed | |
| R01 CA230551 | NCI NIH HHS | United States | R01CA230551 | PubMed and NIH | NIH RePORTER |
| 22902 | Cancer Research UK | United Kingdom | PubMed | PubMed | |
| 100282/Z/12/Z | Wellcome Trust | United Kingdom | PubMed | PubMed | |
| 10589 | Cancer Research UK | United Kingdom | PubMed | PubMed | |
| U01CA230551 | NIH | NIH RePORTER |
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 35449306 | Gut microbes as biomarkers of ICI response - sharpening the focus. | https://conductscience.org/library/papers/35449306 |
Source PubMed
References61
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 31222023 | Establishing microbial composition measurement standards with reference frames. | Nat Commun | 2019 | https://conductscience.org/library/papers/31222023 | PubMed |
| 2 | 11415493 | Nutritional methods in the European Prospective Investigation of Cancer in Norfolk. | Public Health Nutr | 2001 | https://conductscience.org/library/papers/11415493 | PubMed |
| 3 | 31990790 | Gut microbial species and metabolic pathways associated with response to treatment with immune checkpoint inhibitors in metastatic melanoma. | Melanoma Res | 2020 | https://conductscience.org/library/papers/31990790 | PubMed |
| 4 | 23131416 | More than a marine propeller--the flagellum of the probiotic Escherichia coli strain Nissle 1917 is the major adhesin mediating binding to human mucus. | Int J Med Microbiol | 2012 | https://conductscience.org/library/papers/23131416 | PubMed |
| 5 | 26657899 | Proton pump inhibitors affect the gut microbiome. | Gut | 2016 | https://conductscience.org/library/papers/26657899 | PubMed |
| 6 | 41958966 | Bayesian Multinomial Logistic Normal Models through Marginally Latent Matrix-T Processes. | J Mach Learn Res | 2022 | https://conductscience.org/library/papers/41958966 | PubMed |
| 7 | 22661580 | ExPASy: SIB bioinformatics resource portal. | Nucleic Acids Res | 2012 | https://conductscience.org/library/papers/22661580 | PubMed |
| 8 | 28923537 | Metagenomic Shotgun Sequencing and Unbiased Metabolomic Profiling Identify Specific Human Gut Microbiota and Metabolites Associated with Immune Checkpoint Therapy Efficacy in Melanoma Patients. | Neoplasia | 2017 | https://conductscience.org/library/papers/28923537 | PubMed |
| 9 | 32577835 | Gut Microbiome Modulation Via Fecal Microbiota Transplant to Augment Immunotherapy in Patients with Melanoma or Other Cancers. | Curr Oncol Rep | 2020 | https://conductscience.org/library/papers/32577835 | PubMed |
| 10 | 33303685 | Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients. | Science | 2021 | https://conductscience.org/library/papers/33303685 | PubMed |
| 11 | 30422243 | Survival Outcomes in Patients With Previously Untreated BRAF Wild-Type Advanced Melanoma Treated With Nivolumab Therapy: Three-Year Follow-up of a Randomized Phase 3 Trial. | JAMA Oncol | 2019 | https://conductscience.org/library/papers/30422243 | PubMed |
| 12 | 31597568 | Relating the gut metagenome and metatranscriptome to immunotherapy responses in melanoma patients. | Genome Med | 2019 | https://conductscience.org/library/papers/31597568 | PubMed |
| 13 | 34239137 | Gut microbiota signatures are associated with toxicity to combined CTLA-4 and PD-1 blockade. | Nat Med | 2021 | https://conductscience.org/library/papers/34239137 | PubMed |
| 14 | 12826634 | Adherence to a Mediterranean diet and survival in a Greek population. | N Engl J Med | 2003 | https://conductscience.org/library/papers/12826634 | PubMed |
| 15 | 32513234 | Analysis of 1321 Eubacterium rectale genomes from metagenomes uncovers complex phylogeographic population structure and subspecies functional adaptations. | Genome Biol | 2020 | https://conductscience.org/library/papers/32513234 | PubMed |
| 16 | 30936547 | Meta-analysis of fecal metagenomes reveals global microbial signatures that are specific for colorectal cancer. | Nat Med | 2019 | https://conductscience.org/library/papers/30936547 | PubMed |
| 17 | 29183332 | A novel Ruminococcus gnavus clade enriched in inflammatory bowel disease patients. | Genome Med | 2017 | https://conductscience.org/library/papers/29183332 | PubMed |
| 18 | 16632515 | Adjusting batch effects in microarray expression data using empirical Bayes methods. | Biostatistics | 2007 | https://conductscience.org/library/papers/16632515 | PubMed |
| 19 | 33944776 | Integrating taxonomic, functional, and strain-level profiling of diverse microbial communities with bioBakery 3. | Elife | 2021 | https://conductscience.org/library/papers/33944776 | PubMed |
| 20 | 30936548 | Metagenomic analysis of colorectal cancer datasets identifies cross-cohort microbial diagnostic signatures and a link with choline degradation. | Nat Med | 2019 | https://conductscience.org/library/papers/30936548 | PubMed |
Cited by299
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 392 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42972584 | Integrative stratification of response to immunotherapy using host and microbial signatures in patients with advanced non-small cell lung cancer. | Genome Med | 2026 | https://conductscience.org/library/papers/42972584 | PubMed |
| 42965706 | Microbiome-derived TOPOSCORE is associated with response to immune checkpoint inhibitor re-induction after chemotherapy in primary resistant metastatic melanoma. | Cancer Immunol Immunother | 2026 | https://conductscience.org/library/papers/42965706 | PubMed |
| 42955203 | Gut Microbiome Signatures and Immune Checkpoint Inhibitor Response in Gastrointestinal Cancers: Reproducibility and Translational Readiness. | Curr Oncol Rep | 2026 | https://conductscience.org/library/papers/42955203 | PubMed |
| 42947314 | Towards precision microbiome medicine through ecological network balance. | Clin Transl Med | 2026 | https://conductscience.org/library/papers/42947314 | PubMed |
| 42943387 | Precision Microbiome Interventions in Oncology: From Predictive Biomarkers to Therapeutic Modulation of Immunotherapy Outcomes. | Microorganisms | 2026 | https://conductscience.org/library/papers/42943387 | PubMed |
| 42935951 | Microbial-derived metabolites in cancer: evidence boundaries, immune mechanisms and translational pathways. | Front Immunol | 2026 | https://conductscience.org/library/papers/42935951 | PubMed |
| 42920487 | Evaluation of large language models for ICI-related liver injury with an emerging microbiome focus. | Front Cell Infect Microbiol | 2026 | https://conductscience.org/library/papers/42920487 | PubMed |
| 42867969 | BRIDGE-KO: auditable transfer learning with bridged knockoffs improves cross-cohort microbiome prediction of immunotherapy response. | Brief Bioinform | 2026 | https://conductscience.org/library/papers/42867969 | PubMed |
| 42851568 | The microbiome-nitric oxide axis in cancer immunotherapy: a targeted qualitative systematic review of mechanistic and translational evidence. | Front Immunol | 2026 | https://conductscience.org/library/papers/42851568 | PubMed |
| 42848247 | Tumor microenvironment and gut microbiome in immunotherapy resistance in gastric cancer: clinical questions, biological mechanisms, and evidence-based therapeutic perspectives. | Med Oncol | 2026 | https://conductscience.org/library/papers/42848247 | PubMed |
| 42835748 | Digital intelligence-enabled tumor microbiome research: from mechanistic dissection to clinical translation. | Front Oncol | 2026 | https://conductscience.org/library/papers/42835748 | PubMed |
| 42803357 | Lachnospiraceae in the Food-Gut Axis: A Critical Review of Dietary Modulation, Immune Regulation, and Translational Barriers. | Compr Rev Food Sci Food Saf | 2026 | https://conductscience.org/library/papers/42803357 | PubMed |
| 42769860 | From mechanisms to practice: risk management and multidisciplinary decision-making for systemic treatment-related liver injury in HBV-associated hepatocellular carcinoma. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42769860 | PubMed |
| 42769647 | Beyond the tumor microenvironment: a hierarchical immune-circuit model of immune checkpoint blockade resistance. | Front Oncol | 2026 | https://conductscience.org/library/papers/42769647 | PubMed |
| 42763389 | Immune-pressure redistribution in resistance to PD-1/PD-L1 blockade: mechanisms, biomarkers, and therapeutic design. | Mol Cancer | 2026 | https://conductscience.org/library/papers/42763389 | PubMed |
| 42750046 | Decoding the cancer microbiome: multi-omics, AI, and translational opportunities. | Genome Biol | 2026 | https://conductscience.org/library/papers/42750046 | PubMed |
| 42737447 | Microbiome-Immune Interactions as Determinants of Checkpoint Inhibitor Efficacy in Hepatocellular Carcinoma. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42737447 | PubMed |
| 42724816 | Peripheral blood biomarkers in PD-1/PD-L1 immunotherapy: distinguishing predictive from prognostic biomarkers. | Front Immunol | 2026 | https://conductscience.org/library/papers/42724816 | PubMed |
| 42687902 | Pre-treatment T-cell Transcriptional Signatures Predict Immunotherapy Outcomes in Melanoma. | Res Sq | 2026 | https://conductscience.org/library/papers/42687902 | PubMed |
| 42633329 | Gut Microbiome Composition and Response to Immune Checkpoint Inhibitors in Melanoma: A Systematic Review. | Cureus | 2026 | https://conductscience.org/library/papers/42633329 | PubMed |
Genes5
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| BRAF | 673 | PubTator's text mining | https://conductscience.org/library/genes/673 | NCBI Gene |
| CTLA4 | 1493 | PubTator's text mining | https://conductscience.org/library/genes/1493 | NCBI Gene |
| DIMT1 | 27292 | PubTator's text mining | https://conductscience.org/library/genes/27292 | NCBI Gene |
| PDCD1 | 5133 | PubTator's text mining | https://conductscience.org/library/genes/5133 | NCBI Gene |
| TXNL4B | 54957 | PubTator's text mining | https://conductscience.org/library/genes/54957 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/35228751
GET https://conductscience.org/api/papers/v1/35228751/authors?page=2